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Abstract Multispectral imaging (MSI) based on imaging
and spectroscopy, as relatively novel to the field of histo-
pathology, has been used in biomedical multidisciplinary
researches. We analyzed and compared the utility of mul-
tispectral (MS) versus conventional red–green–blue (RGB)
images for immunohistochemistry (IHC) staining to ex-
plore the advantages of MSI in clinical-pathological diag-
nosis. The MS images acquired of IHC-stained membra-
nous marker human epidermal growth factor receptor 2
(HER2), cytoplasmic marker cytokeratin5/6 (CK5/6), and
nuclear marker estrogen receptor (ER) have higher resolu-
tion, stronger contrast, and more accurate segmentation
than the RGB images. The total signal optical density
(OD) values for each biomarker were higher in MS images
than in RGB images (all P<0.05). Moreover, receiver op-
erator characteristic (ROC) analysis revealed that a greater
area under the curve (AUC), higher sensitivity, and speci-
ficity in evaluation of HER2 gene were achieved by MS
images (AUC=0.91, 89.1 %, 83.2 %) than RGB images
(AUC=0.87, 84.5, and 81.8 %). There was no significant
difference between quantitative results of RGB images and
clinico-pathological characteristics (P>0.05). However, by
quantifying MS images, the total signal OD values of
HER2 positive expression were correlated with lymph
node status and histological grades (P=0.02 and 0.04).
Additionally, the consistency test results indicated the
inter-observer agreement was more robust in MS images
for HER2 (inter-class correlation coefficient (ICC)=0.95,
rs=0.94), CK5/6 (ICC=0.90, rs=0.88), and ER (ICC=
0.94, rs=0.94) (all P<0.001) than that in RGB images for
HER2 (ICC=0.91, rs=0.89), CK5/6 (ICC=0.85, rs=0.84),
and ER (ICC=0.90, rs=0.89) (all P<0.001). Our results
suggest that the application of MS images in quantitative
IHC analysis could obtain higher accuracy, reliability, and
more information of protein expression in relation to
clinico-pathological characteristics versus conventional
RGB images. It may become an optimal IHC digital imag-
ing system used in quantitative pathology.
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Introduction
Immunohistochemistry (IHC) has become a potent approach
for detecting antigens in tissues. However, in current clinical
pathology practice, interpreting IHC images is largely based
on the personal experience of the expert pathologist, which is
the major cause of different conclusions on the same IHC
image among the pathologists, and such inter- and intra-
observer variations could pose significant difficulties to
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clinical treatment-decision making [1, 2]. Therefore, in the era
of digital pathology, how to improve the accuracy and repeat-
ability of quantitative analysis of IHC images and minimize
the personal errors remains a formidable task [2]. Previous
study showed that image quality and color variations directly
affect the result of image analysis made by pathologist or
computer-aided image analysis [3].
The conventional red–green–blue (RGB) images by com-
mon imaging technology are difficult to accurately distinguish
labeled targets in the specific target region, due to inherent
technical limitations including suboptimal image contrast
and sharpness, strong light effect, overlapping chromogens,
and varied staining intensities within or between chromogens,
which directly affect the accuracy and repeatability in IHC
image quantification and analysis [4, 5]. A solution to this
problem has to be found so as to improve the current IHC
image reading and reporting system. However, an effective
method to overcome this limitation is to use a multispectral
imaging (MSI) system to acquire images and perform linear
unmixing to separate and quantify each marker without inter-
ference from the others, irrespective of image overlap spatially
[4–6].
Recent developments in MSI systems such as the Nu-
ance™ MSI system have greatly facilitated the imaging,
visualization, and quantitative analysis of single-color or
multicolor tissue samples, both in bright-field images and
fluorescent images [7, 8]. The advantages of MSI over tra-
ditional RGB imaging are to transform black–white or col-
or RGB images with low contrast into spectral images with
high color dimension, and obtain high-resolution images
with precise spectral and spatial information [9, 10]. Such
spectral images could facilitate the extraction of specific
chromogen information from the bright-field image accord-
ing to spectroscopy principle, and such technical advantage
could optimally remove background auto-fluorescence
from the sample and significantly increase the signal-to-
noise ratio (SNR) of the image to enhance the image quality
for subsequent analysis [10, 11].
In routine clinical histopathology, however, it remains un-
known whether the application of MS images in quantitative
IHC analysis could obtain higher sensitivity and specificity,
although some promising results of MSI in automated quan-
titative scoring of IHC have been reported [7, 8, 12, 13]. In
this study, we used invasive breast cancer (BC) IHC images as
the analysis object, and HER2, CK5/6, and ER were selected
for IHC staining to represent interesting biomarkers at the
cellular membrane, cytoplasm, and nucleus, respectively.
The objective of our study is to investigate if the automated
quantification of MS images of the biomarkers could increase
the precision and reliability of image analysis and provide
more information compared with conventional RGB images,
and to develop a standard digital imaging system for IHC
diagnosis in clinical pathology.
Materials and methods
Patients and tumor samples preparation
The study protocol was approved by the Institutional
Ethics Committee of Zhongnan Hospital of Wuhan Univer-
sity and informed consent was obtained from all patients.
The study was undertaken according to the ethical stan-
dards of the World Medical Association Declaration of
Helsinki. Formalin-fixed, paraffin-embedded (FFPE) tis-
sue breast cancer (BC) specimens were obtained from our
prospectively established cancer database, which has been
the source of information for several studies [14–16]. From
this database, 86 patients with invasive BC between 2009
and 2010 were selected for this study. Major clinico-
pathological parameters including age, menopausal status,
the tumor size, lymph node status, histological grade, ER,
and HER2 gene status are summarized in Table 1. TNM
staging and histological grade were classified according to
the seventh edition of American Joint Committee on Can-
cer (AJCC) TNM system [17] and the fourth edition of
WHO histological grade [18]. Serial tissue sections
(4-μm thickness) of invasive BC were prepared for IHC
staining before proceeding to the following imaging stud-
ies (Fig. 1a).
Immunohistochemistry staining and evaluation
Immunostaining of HER2, CK5/6, and ER was performed
using streptavidin-biotin peroxidase complex method (SP).
Major IHC procedures were described previously [19]. In
short (Fig. 1b), tissue slides were first deparaffinized in xy-
lene, ethanol, and water, and then the slides were pretreated in
0.01M citrate buffer (pH 6.0) and heated in a microwave oven
(95 °C) for 15 min. After cooling at room temperature, endog-
enous peroxidase activity was quenched by immersing in 3 %
H2O2 for 10 min to eliminate nonspecific binding. Then,
blocked with 2 % bovine serum albumin (BSA), the slides
were first incubated with primary antibodies of mouse anti-
human polyclonal antibody against HER2 (A-0485, Dako,
Denmark, 1:50 dilution), mouse anti-human monoclonal anti-
body against CK5/6 (ab-86974, Abcam, England, 1:150 dilu-
tion), and rabbit anti-human monoclonal antibody against ER
(sc-7207, Santa Cruz, USA, 1:100 dilution) for 2 h at 37 °C
and then incubated with the corresponding secondary anti-
body (Maixin Biotechnology, China, 1:250 dilution) for
30 min at 37 °C. Primary antibody was replaced with Tris-
buffered saline on section as negative control. The reaction
products were visualized with diaminobenzidine (DAKO,
Denmark). All slides were treated with 0.2 % diaminobenzi-
dine (DAB, DAKO, Denmark) solution for 2 min to develop,
counterstained with hematoxylin, and differentiated by hydro-
chloric acid alcohol.
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The immunostaining results of three biomarkers were
interpreted independently by two expert pathologists
(GF Yang, JP Yuan) in clinical laboratories based on the most
updated pathological guidelines [20]. Tissue slides that were
lost or damaged during sectioning were not scored, and the
number of evaluable cases for each analysis is indicated in
Table 1. In this study, HER2 membranous staining was scored
from 0 to 3+ according to the established criteria [20], and the
data for HER2 staining were categorized into negative (0 and
1+) versus positive (>3+) cases. Cases with HER2 2+ or 3+
score were further analyzed for HER2 gene amplification by
fluorescence in situ hybridization (FISH) technique [21], and
major procedures of FISHwere previously described [22]. For
CK5/6, more than 10 % of the tumor cells with immunostain-
ing along the cellular periphery and/or in the cytoplasm were
defined as positive [23]. The data for ER staining were dichot-
omized into negative (<1 %) versus positive (>1 %) cases
[20].
Image acquisition
The digital images were acquired under an Olympus BX52
bright-field microscope equipped with an Olympus DP72
RGB camera (Olympus Optical Co., Ltd., Tokyo, Japan) and
CRi Nuance multispectral imaging systems (Cambridge Re-
search & Instrumentation, Inc., Woburn, MA, USA) respec-
tively by the following steps. First, the regions of interests
(ROIs) in the IHC images with characteristic invasive BC
were selected at ×100; the necrotic area and ductal carcinoma
in situ were excluded. Second, each ROI containing both
tumor nests and stroma was captured at ×400 following the
unified image acquisition parameters (e.g., ×400 lens magni-
fication, constant light source, autofocus, and exposure time)
by two imaging systems. To minimize selection bias, six high-
power field (HPF) images per slide were randomly selected
from the ROI. For each IHC staining section, a total of six
spectral cubes containing the complete spectral information at
20-nm wavelength intervals from 420 to 720 nm were ran-
domly obtained from different areas of the section by CRi
Nuance multispectral imaging systems. As a result, 1440
bright-field IHC images of three biomarkers were captured
including identical 720 RGB images and 720 MS images,
and all saved in Tagged Image File Format (TIFF) with con-
sistent resolution of 1360×1024 pixels for analysis.
Quantitative image analysis
After imaging acquisition, the software package within
CRi Nuance multispectral imaging system was used for
quantification in MS and RGB images of IHC-positive
areas of HER2, CK5/6, and ER with standard image
unmixing and processing method. The results were ana-
lyzed twice by two expert pathologists (YGF, YJP); all
users train with the software to recognize tumor versus
stroma. CRi Nuance 3.0.0 software was used to build the
spectral libraries and to extract spectral information in
bright-field MS (Fig. 1c1) and RGB (Fig. 1c4) images with
a cube format (RGB images were converted to cube for-
ma t ) . Each ch romogen has i t s un ique spec t r a l
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a ER and HER2 was determined by immunohistochemical staining ac-
cording to guideline [21]
b HER2 gene was determined by fluorescent in situ hybridization (FISH)
according to guideline [22]
HER2 human epidermal growth factor receptor-2, CK5/6 cytokeratin5/6,
ER estrogen receptor
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characteristics (curve), which is the basis for building the
spectral library. The spectral characteristics (curve) for two
chromogens (DAB and hematoxylin) in MS (Fig. 1c2) and
RGB (Fig. 1c5) images were obtained by spectral
unmixing. The spectral library was built from the control
slides, which was used to unmix the positive signals
(DAB) on each test slide by recognizing its unique spectral
curves for quantification. Specific steps of CRi Nuance
software were described [24] and briefed as the following:
(1) selection of targets of HER2, CK5/6, ER, and back-
ground with different spectra; (2) image unmixing and
elimination of background crosstalk: the target images
Fig. 1 The design and major technical procedures of this study. a Tumor
tissue section slides were prepared from 86 selected patients with invasive
BC. b Section slides were stained with three biomarkers in routine IHC,
staining HER2 in cell membrane, CK5/6 in cytoplasm, and ER in cell
nucleus. c1–c5 The MS (c1) and RGB images (c4) were captured and its
spectral curves (c2, c5) were obtained by CRi Nuance software. d1–d4
The positive regions in theMS images (d1, d2) and RGB images (d3, d4)
were unmixed and quantified by CRi Nuance software, respectively, and
the quantitative results of MS and RGB images were compared. BC:
breast cancer; HER2: human epidermal growth factor receptor-2; CK5/
6: cytokeratin5/6; ER: estrogen receptor
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with different spectra were automatically unmixed into
DAB (molecular status) (Fig. 1d1, d3) and hematoxylin
component images by the software based on spectral li-
brary; and (3) quantification of unmixed DAB component
images (Fig. 1d2, d4). HER2, CK5/6, and ER expression
levels stained on IHC slide were best quantitated as total
optical density (OD) values per unit of positive area in one
view field. The final quantitative results of each biomarker
were the average values of the six cube images.
Statistical analysis
All numeric values are reported as the mean ± standard devi-
ation, and Student’s t test of paired data was used to compare
the quantitative results of IHC RGB and MS images of three
biomarkers. Receiver operating characteristic (ROC) curve
analysis was used to compare the accuracy of analysis outputs
of RGB and MS images for HER2 gene using FISH results as
gold standard. Inter-observer variation between the quantita-
tive analysis results of RGB and MS images of three bio-
markers was determined by the use of inter-class correlation
coefficient (ICC) and Spearman’s correlation (rs). ICC≥0.6 is
considered to be acceptable, and >0.7 as good. The one-way
analysis of variance or Student’s t test was used to analyze the
correlations between different image information and the
clinico-pathological features. All statistical analyses were per-
formed using the SPSS Statistics 19.0 software program
(SPSS Institute, Chicago, IL, USA). Two-sided P<0.05 was
considered as statistically significant.
Results
IHC staining results and imaging quality
The expression of HER2, CK5/6, and ER in BC specimens
was studied by IHC. The positive staining was brown or
brownish granules, HER2 was expressed in cell membrane,
CK5/6 was mainly in cell cytoplasm, and ER in cell nucleus.
The overall staining was clear and there was no background
Bnoise^ in the IHC staining. Among the 86 patients in this
study, HER2 was expressed in 45 cases (52.3 %), CK5/6 in
35 cases (40.7 %), and ER in 40 cases (46.5 %, Table 1).
Identical RGB and MS images of these biomarkers were ac-
quired by conventional RGB imaging and MSI system, with
representative IHC images of these markers shown in Fig. 2.
Compared with the RGB images, MS images for each marker
had higher sharpness, stronger contrast, better white balance
processing and color reduction, and more effective removal of
tissue spontaneous light effect, thus ensuring better image
quality for computer analysis.
Unmixing effect of the RGB and MS images
The spectral library was used to unmix the positive signals
(DAB) and the hematoxylin signal on each test slide by rec-
ognizing its unique spectral curves for quantification. After
unmixing the MS images, every individual unmixed single-
channel and composite images thus obtained for three markers
could show clean background, strong object contrast, and
clear positive object silhouette, no matter whether the positive
choromogens are in the membrane (Fig. 3a1–a3), the cyto-
plasm (Fig. 3c1–c3), or the nucleus (Fig. 3e1–e3). In contrast,
every individual unmixed single-channel and composite im-
ages obtained from unmixing RGB images of three markers
could not show clear object segmentation and effective re-
moval of background signal noise, no matter whether the pos-
itive choromogens are in the membrane (Fig. 3b1–b3), the
cytoplasm (Fig. 3d1–d3), or the nucleus (Fig. 3f1–f3).
Quantitative image analysis
The total signal OD values in RGB and MS images of mem-
brane (HER2), cytoplasm (CK5/6), and nucleus (ER) were
measured by CRi Nuance software. All the total signal OD
values of HER2, CK5/6, and ER markers are significantly
higher in MS images than in RGB images, with statistically
significant differences between them (87.510±39.885 vs.
99.833±50.829, P<0.05; 69.917±26.210 vs. 76.205±
29.771, P<0.05; 64.879±24.932 vs. 70.989±27.958,
P<0.05, respectively, Table 2).
Comparisons in HER2 expression among RGB images, MS
images, and FISH
Among the 86 specimens in this study, 45 cases had been
previously identified by IHC as HER2-positive (IHC 2+ in
26 cases and IHC3+ in 19 cases), and specimens from these
45 cases were used for further validation studies by FISH and
comparison studies among the three methods. FISH-positive
results were found in 28 cases, including 11 of the 26 IHC 2+
cases and 17 of the 19 IHC 3+ cases. In order to compare the
quantitative outputs of RGB and MS images, a ROC curve
was generated comparing the diagnostic performance of RGB
and MS images with FISH evaluation as gold standard. The
ROC curve showed that the area under the curve was signif-
icantly greater in MS images (area under the curve (AUC)=
0.91; 95 % confidence interval (CI) 0.878–0.955; P<0.001)
than RGB images (AUC=0.87; 95 % CI 0.830–0.925;
P<0.001). Moreover, the specificity and the sensitivity of
RGB and MS images at optimal cutoffs were also illustrated
in Fig. 4. The sensitivity was slightly higher in MS images
(89.1 %) than in RGB images (84.5 %), and the specificity
was also slightly higher in MS images (83.2 %) than in RGB
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images (81.8 %). The cutoffs of RGB and MS images were
74,074 and 86,420, respectively.
Inter-observer consistency analysis in RGB and MS
images
The agreement analysis on the studied biomarkers showed
that the inter-observer consistency was better in MS images
for membrane (HER2) (ICC=0.95, rs=0.94, P<0.001), cyto-
plasm (CK5/6) (ICC=0.90, rs=0.88, P<0.001), and nucleus
(ER) (ICC=0.94, rs=0.94, P<0.001) than in RGB images for
membrane (HER2) (ICC=0.91, rs=0.89, P<0.001), cyto-
plasm (CK5/6) (ICC=0.85, rs=0.84, P<0.001), and nucleus
(ER) (ICC=0.90, rs=0.89, P<0.001) (Fig. 5).
Quantitative results of different images in relation
to clinico-pathological characteristics
Forty-five HER2-positive expression cases (IHC 2+ in 26
cases and IHC3+ in 19 cases) were used to analyze the rela-
tionship of quantitative results of different images and clinico-
pathological characteristics. As shown in Table 3, we did not
find a statistically significant correlation between the total
signal OD values in RGB images of HER2 and age, meno-
pausal status, tumor size, lymph node status, histological
grades, chemotherapy, and recurrence (P>0.05). It was inter-
esting to note that, by quantifying MS images, quantitative
results of HER2 were correlated with lymph node status and
histological grades; the total signal OD values were higher in
lymph-node-positive than in lymph-node-negative tumors
(P=0.02) and in high-grade than in middle-grade tumors
(P=0.04).
Discussion
Quantitative pathology is the development trend in clinical
diagnostic pathology, which requires two types of key tech-
nology to achieve this goal. First, the imaging technology for
digital pathology with high definition, high resolution, and
high contrast should be developed. Second, the acquisition
and analysis technology with high precision, high throughput,
and high sensitivity should also be developed. Focusing on
common parameters in BC cell membrane, cytoplasm, and
nucleus as the research object, this study attempted to validate
a kind of novel and standard IHC digital imaging technique.
For imaging technology, compared with colorized digital
camera or monochromatic camera, MS imaging can obtain the
information on color spectrum distribution at each pixel of a
color image, whereas conventional RGB imaging can only
obtain information on specific color distribution of the three
available channels (red, green, and blue) [13, 25], as demon-
strated by spectral curves obtained in our results. Previous
studies showed that MS imaging currently uses liquid crystal
tunable filter (LCTF) technology to allow relatively narrow
wavelength bands (10∼20 nm) to transmit wavelengths of
light in the visible and near-infrared ranges, and spectral data
of different wavelengths was acquired. It establishes a three-
dimensional Bcube,^ with each spectrum corresponds to each
pixel point in the cube, and classifies and separates the spec-
trum efficiently and accurately, which can significantly ame-
liorate the imaging process and suit multiple target imaging of
both bright-field and fluorescence images. After the spectral
data is acquired, a high-quality color image is generated from
the image stack (or cube) and displayed [9, 10, 13]. The cor-
responding RGB and MS images of HER-2, CK5/6, and ER
IHC staining in this work were acquired using RGB imaging
Fig. 2 Representative images of immunostaining for three molecular
biomarkers. a–g The RGB images acquired by RGB imaging system.
b–h The corresponding MS images acquired by MSI system. a, b
Positive HER2 membrane staining was scored as 2+. c, d Positive
HER2 membrane staining was scored as 3+. e, f CK5/6 staining mainly
in the cytoplasm; this tumor was classified as CK5/6-positive. g, h ER
staining in the nucleus, this tumor was scored as ER-positive. The
magnification of all figures is ×400. Scale bar: 20 μm for all images
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Fig. 3 MS and RGB images of BC tissues with IHC staining and images
of unmixed signals. a–f The original MS and RGB images of membrane
HER2 (a, b), cytoplasm CK5/6 (c, d), and nucleus ER (e, f). a1–f3
Unmixed DAB, hematoxylin signal, and composite images of MS
images (a1–a3) and RGB images (b1–b3) of HER2, MS images (c1–
c3) and RGB images (d1–d3) of CK5/6, and MS images (e1–e3) and
RGB images (f1–f3) of ER. The magnification of all figures is ×400.
Scale bar: 20 μm for all images
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and MSI system. The imaging results showed that the overall
quality of MS images is improved significantly, with richer
color information, higher resolution, and stronger contrast,
which will help quantitative image analysis. As suggested
by Boucheron et al. [26], MS images are better than the three
standard bands of RGB images not only in color intensity,
image resolution, and color contrast but also in additional
useful information and image segmentation effect.
Previous applications of MSI in pathology mainly focused
on analysis in routine hematoxylin-and-eosin images [26–28],
and the application of this technology in IHC analysis has
been on steady increase. Traditionally, IHC interpretation
may be standardized using current digital imaging technology,
avoiding the use of three- or four-point subjective scoring
methods. Several studies have shown that bright-field RGB
scores were difficult to count exactly, as the tumor cells al-
ways overlap one another [5, 6, 11, 29]. However, MSI can
allow one to separate overlapping chromogens and unmix
multiple chromogens in multicolor IHC [11, 25, 30].
Accurate signal unmixing are prerequisites for valid quan-
titation of IHC-positive signal intensities. Quantitation typi-
cally requires some spatial manipulations such as segmenta-
tion of morphologic tissue and identification of subcellular
compartments [30]. In order to effectively analyze captured
images, the software employed must be able to extract chro-
mogenic intensity information from the images [5, 30]. In our
study, we observed the unmixed effect of different chromo-
gens in RGB and MS images by CRi Nuance software pack-
age. It is simple to obtain clearer separated quantitative images
and better segmentation accuracy from unmixing MS images
of each marker than RGB images, no matter whether positive
choromogens occurred in the membrane, the cytoplasm, or the
nucleus. In order to visualize the co-localization better, these
unmixed images can be recolored and layered together as
composite images, rendering a simulated bright-field view.
Therefore, the richer color information contained in MS im-
ages is more suitable for image quantitative analysis than con-
ventional RGB images.
In BC patients, accurate assessment of hormone receptor
(HR), HER2 status, and CK5/6 of the tumor is critical for
defining the molecular subtypes and predicting response to
systemic therapies [21, 31, 32]. We measured the total signal
OD values in RGB and MS images of membrane (HER2),
cytoplasm (CK5/6), and nucleus (ER) in invasive BC using
CRi Nuance software package. The results showed that the
total signal OD values were higher in MS images than the
corresponding RGB images, and the differences achieved sta-
tistical significance (P<0.01, for all). This possibly due toMS
images contain stronger color intensities and more precise
segmented capacities. However, whether high numerical
quantitative results can obtain high diagnostic coincidence
Table 2 Quantitative image
analysis of HER2, CK5/6, and ER
by CRi Nuance software
Marker Images (n) Total signal OD values (×103) T value P value
RGB images MS images
HER2 540 87.510±39.885 99.833±50.829* −13.557 0.000
CK5/6 420 69.917±26.210 76.205±29.771* −12.641 0.000
ER 480 64.879±24.932 70.989±27.958* −13.482 0.000
Data were presented as means ± standard deviation
OD optical density
*P<0.05 compared with RGB images
Fig. 4 ROC analysis of quantitative outputs of RGB and MS images
with FISH as gold standard. MS images have significantly increased
area under the ROC curve, sensitivity, and specificity than the RGB
images. The application of MS images in quantitative IHC could have
better diagnostic performance in BC patients
Fig. 5 Inter-observer concordance between IHC quantitative analysis for
MS andRGB images, shown as dotplots (Spearman’s rank correlation). a,
b Correlations of membrane HER2 scores in MS versus RGB images
(rs=0.94 vs. 0.89, all P<0.001). c, d Correlations of cytoplasm CK5/6
scores in MS versus RGB images (rs=0.88 vs. 0.84, all P<0.001). e, f
Correlations of nucleus ER scores inMS versus RGB images (rs=0.94 vs.
0.89, all P<0.001)
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rate remains to be seen. Our previous studies also showed that
MSI could be applied to QD-based fluorescence imaging to
help improve tumor classifications and predict tumor progno-
sis [15].
In the validation study using HER2 as a model, we com-
pared the MS images analysis outputs, RGB images analysis
outputs, and FISH results. ROC curve analysis, a useful meth-
od to evaluate the performance of diagnostic systems, showed
greater AUC, higher specificity, and sensitivity in MS images
than RGB images. These results indicate that the MS images
could facilitate better diagnostic performance than RGB im-
ages. Huang et al. [13] demonstrated that MSI technology is
reliable for objective and high-throughput biomarker quanti-
tation and colocalization study using chromogenic
multiplexed immunohistochemistry.
By measuring RGB images, we found no significant dif-
ference between HER2 expression and age, menopausal sta-
tus, tumor size, lymph node status, histological grades, che-
motherapy, recurrence (P>0.05). However, by quantifying
MS images, we first reported that quantitative results of
HER2 expression had relation to the lymph node status and
histological grades of invasive BC; the total signal OD values
were higher in lymph-node-positive than in lymph-node-
negative tumors and in high-grade tumors than in middle-
grade tumors (P=0.02 and 0.04). It seems that more informa-
tion could be provided by quantifying MS images of the pro-
tein expression in relation to differentiation of invasive BC.
In addition, consistency analysis results showed that quan-
titative evaluation of MS images of membrane (HER2), cyto-
plasm (CK5/6), and nucleus (ER) reached a better inter-
observer agreement and reproducibility than RGB images.
Although some factors may influence inter-observer variabil-
ity such as application of software and observers themselves,
this indicates that quantitative estimation of MS images of
specific biomarker may be sufficient for reliable and robust
measurement of IHC in invasive breast carcinoma.
Our study has several limitations. First, although 86 BC
specimens were enrolled in our study, it finally included only
45 HER2-positive, 35 CK5/6-positive, and 40 ER-positive
cases, which could result in possible sample selection bias
and would have been more justifiable with more subjects.
Second, the objective evaluation including mean squared error
Table 3 HER2 immunohistochemical score for RGB and MS images in relation to clinico-pathological characteristics
Variables Total HER-positive
(n)
RGB images MS images
No. Total signal OD (×103) P value No. Total signal OD (×103) P value
Age (years) 0.36 0.34
<50 32 21 126 84.586±40.154 126 96.149±84.650
>50 54 24 144 91.376±75.847 144 100.192±68.947
Menopausal status 0.68 0.47
Premenopausal 29 22 132 87.019±39.937 132 91.442±43.603
Postmenopausal 57 23 138 90.150±76.720 138 96.634±69.388
Tumor size (cm) 0.17 0.14
T≤5 70 30 180 89.421±42.474 180 102.881±44.085
T>5 16 15 90 97.146±48.849 90 111.183±51.048
Lymph node status 0.06 0.02
Positive 36 25 150 96.097±48.255 150 109.118±73.246
Negative 50 20 120 86.078±35.243 120 90.013±38.430
Histological grades 0.46 0.04
І 17 6 36 59.678±13.464 36 59.631±18.893
П 46 21 126 85.370±50.951 126 92.379±41.402
Ш 23 18 108 91.265±39.603* 108 102.995±41.097*
Chemotherapy 0.48 0.31
No 37 19 114 90.186±19.246 114 92.851±21.654
Yes 49 26 156 85.279±69.983 156 89.544±29.129
Recurrence 0.73 0.59
No 51 22 132 97.925±31.951 168 104.835±35.558
Yes 35 23 138 99.435±40.661 102 102.305±42.811
Data are presented as means ± standard deviation
OD optical density
*P<0.05 compared with histological grade П
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(MSE), peak signal-to-noise ratio (PSNR), and structural sim-
ilarity (SSIM) [33] of different image types was not performed
in our results on the ground that we primarily focused on
comparing their sensitivity, specificity, and application effect
in automated quantitative analysis of IHC. Additional studies
are needed to identify the advantages of spectral image by
calculating accurately the objective evaluation index of the
image. Third, the analysis software used in this study could
not eliminate the interference caused by three biomarkers
expressed in the stroma, although such expression in the stro-
ma is very little, and we are comparing two kinds of digital
images under the same conditions. Fourth, despite higher sen-
sitivity and specificity and more accurate quantification inMS
images than conventional RGB images, we did not assess the
relationship between quantitative analysis of different images
and prognosis of invasive BC. Further prospective clinical
studies are required to validate the advantages of MS images.
In conclusion, our study demonstrates the potential of MSI
in quantitative analysis of IHC and highlights the inherent
advantages of more accurate spectra quantification of MS im-
ages over conventional RGB images. Based on these advan-
tages, an improved technical platform for IHC digital imaging
could be developed for computer-aided quantitative digital
pathology.
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